BioPharma Dive12h
Axsome secures top drug’s future with Teva patent settlement
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
Insomnia: What Exactly Is It & How Do I Treat It?
People with insomnia can have frequent difficulty falling asleep, staying asleep, and getting good-quality sleep.
Shares in Biopharma Firm Axsome Surge Over 20% After Settling Teva Patent Dispute
Shares in biopharmaceutical group Axsome Therapeutics (AXSM) surged 23% today after it said it had settled a legal dispute ...
Neurodiagnostics Market Set To Surge To $12.89 Billion By 2030 At A 7% CAGR
Neurodiagnostics Market Research Report In 2020, the global neurodiagnostics market was valued at $6,530 million and is projected to reach ...
manilatimes16h
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr - bupropion HCl) Patent Litigation
The settlement agreement resolves all outstanding patent litigation relating to AUVELITY.
Rolling Out11h
Why doctors hide this sleep and memory risk
New research uncovers a hidden link between sleep apnea and memory, especially in women. Learn how sleep quality impacts cognitive health.
pulmonologyadvisor15h
Sleep Apnea Surgery Linked to Lower Risk for Car Accidents for Patients
For patients with OSA, sleep surgery is associated with a significantly reduced risk for MVA compared with CPAP therapy or no treatment.